Neuland Laboratories Limited (NEULANDLAB) — Announcement

· NSE Neutral
📢 Key Event
Company to present at Nuvama India Conference 2026 in London
💡 Investor Takeaway
Investors should monitor for strategic updates following management discussions at the London conference.

Neuland Laboratories announced its participation in the Nuvama India Conference 2026 in London on June 8-9, 2026, offering group and one-on-one meetings with analysts and institutional investors. The filing confirms the event dates and location but notes the schedule may change due to participant or company exigencies, signaling proactive engagement with global investors ahead of potential strategic updates.

📄 View Original Announcement (PDF)

About Neuland Laboratories Limited (NEULANDLAB)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹21,284.79 Cr P/E: 71.0

View full NEULANDLAB stock details →

📡 Get AI alerts when NEULANDLAB files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track NEULANDLAB — Free

📊 More NEULANDLAB filings

See all NEULANDLAB filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

📡 Get AI alerts when NEULANDLAB files new disclosures

Track NEULANDLAB filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track NEULANDLAB — Free

Free account · 2 AI queries/day